58
Views
153
CrossRef citations to date
0
Altmetric
Cell Growth and Development

p38 Mitogen-Activated Protein Kinase-Dependent Activation of Protein Phosphatases 1 and 2A Inhibits MEK1 and MEK2 Activity and Collagenase 1 (MMP-1) Gene Expression

, , , &
Pages 2373-2383 | Received 19 Jul 2000, Accepted 04 Jan 2001, Published online: 27 Mar 2023

REFERENCES

  • Abraham, D., K. Podar, M. Pacher, M. Kubicek, N. Welzel, B. A. Hemmings, S. M. Dilworth, H. Mischak, W. Kolch, and M. Baccarini. 2000. Raf-1-associated PP2A as a positive regulator of kinase activation. J. Biol. Chem. 275:22300–22304.
  • Bruder, J. T., G. Heidecker, and U. R. Rapp. 1992. Serum, TPA-, and Ras-induced expression from Ap-1/Ets driven promoters requires Raf-1 kinase. Genes Dev. 6:545–556.
  • Casillas, A. M., K. Amaral, S. Chegini Farahani, and A. E. Nel. 1993. Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate. Biochem. J. 290:545–550.
  • Cavigelli, M., W. W. Li, A. Lin, B. Su, K. Yoshioka, and M. Karin. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15:6269–6279.
  • Chen, Y., S. Lin-Shiau, and J. Lin. 1998. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell. Physiol. 177:324–333.
  • Chung, H., and D. Brautigan. 1999. Protein phosphatase 2A suppresses MAP kinase signalling and ectopic protein expression. Cell. Signal. 11:575–580.
  • Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137–1146.
  • Cuenda, A., P. Cohen, V. Buee Scherrer, and M. Goedert. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:295–305.
  • Doza, Y., C. Hall-Jackson, and P. Cohen. 1998. Arsenite blocks growth factor induced activation of MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos. Oncogene 17:19–24.
  • Enslen, H., D. M. Brancho, and R. J. Davis. 2000. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 19:1301–1311.
  • Favre, B., P. Turowski, and B. A. Hemmings. 1997. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 272:13856–13863.
  • Fort, P., L. Marty, M. Piechaczyk, S. el Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431–1442.
  • Frisch, S. M., R. Reich, I. E. Collier, L. T. Genrich, G. Martin, and G. I. Goldberg. 1990. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene 5:75–83.
  • Frost, J. A., A. S. Alberts, E. Sontag, K. Guan, M. C. Mumby, and J. R. Feramisco. 1994. Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity. Mol. Cell. Biol. 14:6244–6252.
  • Frost, J. A., T. D. Geppert, M. H. Cobb, and J. R. Feramisco. 1994. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA 91:3844–3848.
  • Ganiatsas, S., L. Kwee, Y. Fujiwara, A. Perkins, T. Ikeda, M. Labow, and L. Zon. 1998. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA 95:6881–6886.
  • Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211–218.
  • Goldberg, G. I., S. M. Wilhelm, A. Kronberger, E. A. Bauer, G. A. Grant, and A. Z. Eisen. 1986. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261:6600–6605.
  • Goldberg, Y.. 1999. Protein phosphatase 2A: who shall regulate the regulator?. Biochem. Pharmacol. 57:321–328.
  • Han, J., X. Wang, Y. Jiang, R. J. Ulevitch, and S. Lin. 1997. Identification and characterization of a predominant isoform of human MKK3. FEBS Lett. 403:19–22.
  • Huang, C., W.-Y. Ma, J. Li, A. Goranson, and Z. Dong. 1999. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J. Biol. Chem. 274:14595–14601.
  • Inoue, T., M. Yashiro, S. Nishimura, K. Maeda, T. Sawada, Y. Ogawa, M. Sowa, and K. H. Chung. 1999. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int. J. Mol. Med. 4:73–77.
  • Ivaska, J., H. Reunanen, J. Westermarck, L. Koivisto, V.-M. Kähäri, and J. Heino. 1999. Integrin α2β1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the α2 cytoplasmic tail. J. Cell Biol. 147:401–416.
  • Jahan, I., K. Mihara, L. Bai, and M. Namba. 1993. Neoplastic transformation and characterization of human fibroblasts by treatment with 60Co gamma rays and the human c-Ha-ras oncogene. In Vitro Cell. Dev. Biol. 29A:763–767.
  • Kähäri, V.-M., and U. Saarialho-Kere. 1999. Matrix metalloproteinases and their inhibitors in tumor invasion. Ann. Med. 31:34–45.
  • Keyse, S.. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186–192.
  • Korzus, E., H. Nagase, R. Rydell, and J. Travis. 1997. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 272:1188–1196.
  • Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
  • Lim, C. P., N. Jain, and X. Cao. 1998. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16:2915–2926.
  • Lu, H. T., D. D. Yang, M. Wysk, E. Gatti, I. Mellman, R. J. Davis, and R. A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1845–1857.
  • Ludwig, S., A. Hoffmeyer, M. Goebeler, K. Kilian, H. Häfner, B. Neufeld, J. Han, and U. Rapp. 1998. The stress inducer arsenite activates mitogen-activated protein extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273:1917–1922.
  • Millward, T. A., S. Zolnierowicz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186–191.
  • Molnar, A., A. Theodoras, L. Zon, and J. Kyriakis. 1997. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:13229–13235.
  • Moriguchi, T., N. Kuroyanagi, K. Yamaguchi, Y. Gotoh, K. Irie, T. Kano, K. Shirakabe, Y. Muro, H. Shibuya, K. Matsumoto, E. Nishida, and M. Hagiwara. 1996. A. novel kinase cascade mediated by mitogen-activated protein kinase 6 and MKK3. J. Biol. Chem. 271:13675–13679.
  • Murray, G. I., M. E. Duncan, P. O'Neil, W. T. Melvin, and J. E. Fothergill. 1996. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2:461–462.
  • Nemoto, S., J. Xiang, S. Huang, and A. Lin. 1998. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J. Biol. Chem. 273:16415–16420.
  • New, L., Y. Jiang, M. Zhao, K. Liu, W. Zhu, L. J. Flood, Y. Kato, G. C. Parry, and J. Han. 1998. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17:3372–3384.
  • Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247–1255.
  • Ravanti, L., L. Häkkinen, H. Larjava, U. Saarialho-Kere, M. Foschi, J. Han, and V.-M. Kähäri. 1999. Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J. Biol. Chem. 274:37292–37300.
  • Reunanen, N., J. Westermarck, L. Häkkinen, T. H. Holmström, I. Elo, J. E. Eriksson, and V.-M. Kähäri. 1998. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273:5137–5145.
  • Ridley, S. H., S. J. Sarsfield, J. C. Lee, H. F. Bigg, T. E. Cawston, D. J. Taylor, D. L. DeWitt, and J. Saklatvala. 1997. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158:3165–3173.
  • Rutter, G. A., M. R. White, and J. M. Tavare. 1995. Involvement of MAP kinase in insulin signalling revealed by noninvasive imaging of luciferase gene expression in single living cells. Curr. Biol. 5:890–899.
  • Sabapathy, K., Y. Hu, T. Kallunki, M. Schreiber, J. P. David, W. Jochum, E. F. Wagner, and M. Karin. 1999. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9:116–125.
  • Shapiro, S.. 1998. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10:602–608.
  • Shirakabe, K., K. Yamaguchi, H. Shibuya, K. Irie, S. Matsuda, T. Moriguchi, Y. Gotoh, K. Matsumoto, and E. Nishida. 1997. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272:8141–8144.
  • Su, G. H., W. Hilgers, M. C. Shekher, D. J. Tang, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1998. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58:2339–2342.
  • Teng, D. H., W. L. Perry III, J. K. Hogan, M. Baumgard, R. Bell, S. Berry, T. Davis, D. Frank, C. Frye, T. Hattier, R. Hu, S. Jammulapati, T. Janecki, A. Leavitt, J. T. Mitchell, R. Pero, D. Sexton, M. Schroeder, P. H. Su, B. Swedlund, J. M. Kyriakis, J. Avruch, P. Bartel, A. K. Wong, A. Oliphant, A. Thomas, M. H. Skolnick, and S. V. Tavtigian. 1997. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57:4177–4182.
  • Virshup, D. M.. 2000. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. 12:180–185.
  • Wang, Y., S. Huang, V. P. Sah, J. Ross Jr., J. H. Brown, J. Han, and K. R. Chien. 1998. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:2161–2168.
  • Wassarman, D. A., N. M. Solomon, H. C. Chang, F. D. Karim, M. Therrien, and G. M. Rubin. 1996. Protein phosphatase 2A positively and negatively regulates Ras1-mediated photoreceptor development in Drosophila. Genes Dev. 10:272–278.
  • Westermarck, J., T. Holmström, M. Ahonen, J. E. Eriksson, and V.-M. Kähäri. 1998. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 17:547–557.
  • Westermarck, J., and V.-M. Kähäri. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:781–792.
  • Westermarck, J., J. Lohi, J. Keski Oja, and V.-M. Kähäri. 1994. Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB. Cell Growth Differ. 5:1205–1213.
  • Westermarck, J., A. Seth, and V.-M. Kähäri. 1997. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14:2651–2660.
  • Wilkinson, G. W., and A. Akrigg. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20:2233–2239.
  • Wysk, M., D. D. Yang, H. T. Lu, R. A. Flavell, and R. J. Davis. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96:3763–3768.
  • Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331.
  • Yamaguchi, K., K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida, and K. Matsumoto. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008–2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.